Texas Life Science Forum: Mongoose Bio is advancing a novel TCR-T program that was developed at MD Anderson and plans to take it into the clinic next year
CEO Neil Warma describes the unique approach to TCRs that could reduce toxicity and increase persistence compared to other programs. Plus, his view from beings a veteran to the Houston biotech scene.
Brought to you by